-
The Serum Institute of India (SII), the world's largest vaccine manufacturer by volume, is manufacturing a version of the Oxford-AstraZeneca Covid-19 vaccine named 'Covishield' in India.
-
"The benefits in preventing a Covid-19 infection and its complications continue to outweigh any risks and the public should continue to get their vaccine when invited to do so," dpa news agency quoted June Raine
-
Vaccine hesitant people may have anxiety over safety concerns, or they might belong to a community that historically has mistrusted the medical establishment, according to the study.
-
Investigators said the vaccine was effective across all ages, including older people — which previous studies in other countries had failed to establish.
-
Taiwan has signed contracts securing 10 million doses of the AstraZeneca vaccine, 5.05 million doses of the Moderna vaccine, and 4.76 million doses of vaccines through COVAX.
-
The move paved the way for more than a dozen European countries, which had suspended use of the shot over the past week, to begin using it again.
-
Germany, France, Italy and Spain were among countries that suspended use of the vaccine on Monday.
-
Germany, France, Italy and Spain joined the growing list of mostly European countries — starting with Denmark last week — that temporarily halted use of the AstraZeneca vaccine.
-
Thailand last week was the first country outside Europe to temporarily suspend using the AstraZeneca vaccine.
-
"Safety is of paramount importance and the Company is continually monitoring the safety of its vaccine," the company said in a statement on Sunday.
-
Earlier on Sunday, Ireland suspended the use of the AstraZeneca vaccine as new information emerged on blood clotting incidents in Norway.
-
Apart from Denmark, Norway and Iceland have also temporarily suspended the use of AstraZeneca's Covid-19 vaccine.
-
Yong Poovorawan, an advisor to Thailand's vaccination program, said the delay, pending an investigation into the cause of the reported side effect, will not have a big impact on the rollout.
-
Health care workers, especially those who have direct contact with suspected or confirmed COVID-19 cases, will be the first to get the shots.
-
The vaccinations began as South Korea reported another 406 new infections on Friday, bringing its total for the pandemic to 88,922, including 1,585 deaths.
-
The West African nation of 30 million has recorded 81,245 cases and 584 deaths since the beginning of the pandemic, according to figures from Ghana's Health Services on Tuesday.
-
Different types of COVID-19 vaccines have been authorised and it's possible side effects will differ for each.
-
The coronavirus has infected more than 109 million people and killed at least 2.4 million of them.
-
Covishield is the brand name for the AstraZeneca-Oxford University COVID-19 vaccine.
-
As indirect evidence is compatible with protection against severe Covid-19, the situation remains to be demonstrated in ongoing clinical trials and post-implementation evaluations.